Vaccines and global health: In search of a sustainable model for vaccine development and delivery
- PMID: 31217336
- DOI: 10.1126/scitranslmed.aaw2888
Vaccines and global health: In search of a sustainable model for vaccine development and delivery
Abstract
Most vaccines for diseases in low- and middle-income countries fail to be developed because of weak or absent market incentives. Conquering diseases such as tuberculosis, HIV, malaria, and Ebola, as well as illnesses caused by multidrug-resistant pathogens, requires considerable investment and a new sustainable model of vaccine development involving close collaborations between public and private sectors.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Similar articles
-
Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.Expert Rev Vaccines. 2009 May;8(5):529-42. doi: 10.1586/erv.09.18. Expert Rev Vaccines. 2009. PMID: 19397410 Review.
-
Quadrivalent meningococcal conjugate vaccines.Vaccine. 2009 Jun 24;27 Suppl 2:B30-41. doi: 10.1016/j.vaccine.2009.05.003. Epub 2009 May 27. Vaccine. 2009. PMID: 19477560 Review.
-
[Meningococcal vaccines: from polysaccharide to conjugate vaccines].Arch Pediatr. 2012 Sep;19 Suppl 2:S61-4. doi: 10.1016/S0929-693X(12)71275-7. Arch Pediatr. 2012. PMID: 22883368 French.
-
Meningococcal vaccine use in college students.Ann Pharmacother. 2002 Nov;36(11):1776-84. doi: 10.1345/aph.1C024. Ann Pharmacother. 2002. PMID: 12398576 Review.
-
Global Advisory Committee on Vaccine Safety, 12-13 December 2007.Wkly Epidemiol Rec. 2008 Jan 25;83(4):37-44. Wkly Epidemiol Rec. 2008. PMID: 18219807 English, French. No abstract available.
Cited by
-
A universal design of restructured dimer antigens: Development of a superior vaccine against the paramyxovirus in transgenic rice.Proc Natl Acad Sci U S A. 2024 Jan 23;121(4):e2305745121. doi: 10.1073/pnas.2305745121. Epub 2024 Jan 18. Proc Natl Acad Sci U S A. 2024. PMID: 38236731
-
Attitudes towards COVID Vaccine and Vaccine Hesitancy in Dermatology: A Narrative Review.Vaccines (Basel). 2023 Aug 15;11(8):1365. doi: 10.3390/vaccines11081365. Vaccines (Basel). 2023. PMID: 37631933 Free PMC article. Review.
-
Factors, enablers and challenges for COVID-19 vaccine development.BMJ Glob Health. 2023 Jun;8(6):e011879. doi: 10.1136/bmjgh-2023-011879. BMJ Glob Health. 2023. PMID: 37277195 Free PMC article. Review.
-
Advances in Computational and Bioinformatics Tools and Databases for Designing and Developing a Multi-Epitope-Based Peptide Vaccine.Int J Pept Res Ther. 2023;29(4):60. doi: 10.1007/s10989-023-10535-0. Epub 2023 May 23. Int J Pept Res Ther. 2023. PMID: 37251529 Free PMC article. Review.
-
Vaccine supply chain management: An intelligent system utilizing blockchain, IoT and machine learning.J Bus Res. 2023 Feb;156:113480. doi: 10.1016/j.jbusres.2022.113480. Epub 2022 Dec 2. J Bus Res. 2023. PMID: 36506475 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
